Bittam Exchange Exposed: Why This Broker Is a High-Risk Platform
With a dangerously low WikiBit score of 3.06 out of 10 and serious questions surrounding its regulatory claims, Bittam Exchange has emerged as a high-risk platform that traders cannot afford to overlook.
Prediction market boom spurs new VC fund backed by Polymarket, Kalshi CEOs
A new venture capital firm focused on prediction markets is launching with backing from Polymarket founder and CEO Shayne Coplan and Kalshi co-founder and
Ex‑Kalshi staff launch $35M fund for prediction market infrastructure
Two early Kalshi alumni are raising up to $35M for 5c(c) Capital, a fund backed by Kalshi and Polymarket CEOs to invest in market makers, indices and
RUNE Technical Analysis Mar 23
RUNE is stuck in the neutral zone with RSI at 46.84 while MACD gives a bearish momentum signal with its negative histogram; the price remaining below the
UnitedHealth (UNH) Stock Faces Pressure from Analyst Downgrades and Regulatory Challenges
Key Takeaways Shares began trading at $277.32, significantly below the 52-week peak of $606.36 Wall Street firms reduced price targets — JPMorgan to $389,
Dogecoin Risks 23% Crash as Descending Triangle Nears Breakdown
Dogecoin is trading at $0.09515, up 5.44% in the last 24 hours. A descending triangle has compressed prices since January, when DOGE climbed above $0.14.
Ex‑Kalshi staff launch $35M fund for prediction market infrastructure
Two early Kalshi alumni are raising up to $35M for 5c(c) Capital, a fund backed by Kalshi and Polymarket CEOs to invest in market makers, indices and
Prediction market boom spurs new VC fund backed by Polymarket, Kalshi CEOs
A new venture capital firm focused on prediction markets is launching with backing from Polymarket founder and CEO Shayne Coplan and Kalshi co-founder and
RUNE Technical Analysis Mar 23
RUNE is stuck in the neutral zone with RSI at 46.84 while MACD gives a bearish momentum signal with its negative histogram; the price remaining below the
UnitedHealth (UNH) Stock Faces Pressure from Analyst Downgrades and Regulatory Challenges
Key Takeaways Shares began trading at $277.32, significantly below the 52-week peak of $606.36 Wall Street firms reduced price targets — JPMorgan to $389,
Pinakabagong Balita
Walang datos